Refludan Powder For Solution For Injection 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Refludan: Powder for solution for injection (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LEPIRUDIN is an anticoagulant. It is used in a hospital setting to help prevent blood clots.

In-Depth Information

Refludan 50mg Powder for Injection

NDC: 504190150
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Heparin-induced Thrombocytopenia, Thrombosis Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Acute Myocardial Infarction, Unstable Angina

Storage Information
Store between 36 to 77 degrees F
Refludan 50mg Powder for Injection

Reported Side Effects for Refludan 50mg Powder for Injection

Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Laryngeal Edema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Coughing Up Blood Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Bleeding In The Abdomen Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding In The Brain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Breathing Difficulties Incidence:
1.0-9.9%*
Severity: SEVERE
Onset: RAPID
Shortness Of Breath Incidence:
1.0-9.9%*
Severity: MODERATE
Onset: EARLY
Cough Incidence:
1.0-9.9%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
1.8%*
Severity: MILD
Onset: DELAYED
Vaginal Bleeding Incidence:
1.8%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
1.8%*
Severity: SEVERE
Onset: DELAYED
Blood In The Urine Incidence:
4.4%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
4.4%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
4.4%*
Severity: MILD
Onset: DELAYED
Intestinal Bleeding Incidence:
5.3%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
10.6%*
Severity: MODERATE
Onset: EARLY
Bruise Incidence:
10.6%*
Severity: MODERATE
Onset: EARLY
Anemia Incidence:
12.4%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Refludan

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5